These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2221157)

  • 21. Trifluoperazine plasma levels and clinical response.
    Janicak PG; Javaid JI; Sharma RP; Comaty JE; Peterson J; Davis JM
    J Clin Psychopharmacol; 1989 Oct; 9(5):340-6. PubMed ID: 2794098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF noradrenaline and schizophrenia.
    Kemali D; Maj M
    Am J Psychiatry; 1986 Jan; 143(1):126-7. PubMed ID: 3942277
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma HVA in psychiatric patients: longitudinal studies.
    Javaid JI; Sharma RP; Janicak PG; Davis JM
    Psychopharmacol Bull; 1990; 26(3):361-5. PubMed ID: 2274637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.
    Prell GD; Green JP; Kaufmann CA; Khandelwal JK; Morrishow AM; Kirch DG; Linnoila M; Wyatt RJ
    Schizophr Res; 1995 Jan; 14(2):93-104. PubMed ID: 7711000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
    Pillai A; Kale A; Joshi S; Naphade N; Raju MS; Nasrallah H; Mahadik SP
    Int J Neuropsychopharmacol; 2010 May; 13(4):535-9. PubMed ID: 19941699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract]   [Full Text] [Related]  

  • 27. CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.
    Sharma RP; Javaid JI; Faull K; Davis JM; Janicak PG
    Psychiatry Res; 1994 Jan; 51(1):51-60. PubMed ID: 7910975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased noradrenaline levels in CSF and plasma of schizophrenic patients.
    Kemali D; Del Vecchio M; Maj M
    Biol Psychiatry; 1982 Jun; 17(6):711-7. PubMed ID: 7104421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.
    Sharma RP; Javaid JI; Pandey GN; Janicak PG; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):459-66. PubMed ID: 1657221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma noradrenaline and clinical psychopathology in schizophrenia. A correlation analysis.
    Dajas F; Barbeito L; Martinez-Pesquera G; Lista A; Puppo D; Puppo-Touriz H
    Neuropsychobiology; 1983; 10(2-3):70-4. PubMed ID: 6674828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM
    Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of psychotic inpatients with high or low HVA levels at admission.
    Bowers MB
    Am J Psychiatry; 1991 Feb; 148(2):240-3. PubMed ID: 1670980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M; Davis KL
    Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free and conjugated plasma homovanillic acid in schizophrenic patients.
    Garcia A; Galinowski A; Guicheney P; Mignot E; Loo H; Meyer P
    Biol Psychiatry; 1989 May; 26(1):87-96. PubMed ID: 2720023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type.
    Neeman G; Blanaru M; Bloch B; Kremer I; Ermilov M; Javitt DC; Heresco-Levy U
    Am J Psychiatry; 2005 Sep; 162(9):1738-40. PubMed ID: 16135636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis.
    Walker EF; Bonsall R; Walder DJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Mar; 15(1):10-7. PubMed ID: 11877547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
    Schulz E; Remschmidt H; Fleischhaker C
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects.
    Sharma R; Javaid JI; Janicak P; Comaty J; Davis JM; Faull K
    Am J Psychiatry; 1988 Nov; 145(11):1480-1. PubMed ID: 3189613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.